ENDRA Life Sciences (NDRA) Invested Capital: 2016-2021
Historic Invested Capital for ENDRA Life Sciences (NDRA) over the last 5 years, with Sep 2021 value amounting to $13.2 million.
- ENDRA Life Sciences' Invested Capital rose 294.49% to $13.2 million in Q3 2021 from the same period last year, while for Sep 2021 it was $13.2 million, marking a year-over-year increase of 294.49%. This contributed to the annual value of $7.8 million for FY2020, which is 63.39% up from last year.
- Latest data reveals that ENDRA Life Sciences reported Invested Capital of $13.2 million as of Q3 2021, which was down 12.23% from $15.0 million recorded in Q2 2021.
- ENDRA Life Sciences' 5-year Invested Capital high stood at $17.9 million for Q1 2021, and its period low was -$1.4 million during Q1 2017.
- Moreover, its 3-year median value for Invested Capital was $3.8 million (2019), whereas its average is $6.6 million.
- Per our database at Business Quant, ENDRA Life Sciences' Invested Capital plummeted by 106.38% in 2018 and then skyrocketed by 1,434.47% in 2021.
- ENDRA Life Sciences' Invested Capital (Quarterly) stood at $5.3 million in 2017, then increased by 18.44% to $6.2 million in 2018, then decreased by 23.81% to $4.8 million in 2019, then surged by 63.39% to $7.8 million in 2020, then spiked by 294.49% to $13.2 million in 2021.
- Its Invested Capital stands at $13.2 million for Q3 2021, versus $15.0 million for Q2 2021 and $17.9 million for Q1 2021.